Related Experiment Video
Updated: Dec 20, 2025

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
Published on: March 30, 2019
MAP7 interacts with RC3H1 and cooperatively regulate cell-cycle progression of cervical cancer cells via activating
Rong Zhang1, Lei Li2, Lingli Chen3
1Department of Gynecology and Obstetrics, Tianjin Medical University General Hospital, Tianjin, 300052, China; Department of Gynecology and Obstetrics, People's Hospital of Shanxi Province, Taiyuan, 030012, China.
Abstract:
Ensconsin is encoded by the MAP7 gene and belongs to the microtubule-associated proteins. This study aimed to explore its functional roles and partners in cell-cycle progression in cervical cancer. Data from the Cancer Genome Atlas-Cervical & Endocervical Cancer (TCGA-CESC) and the Genotype-Tissue Expression project were used for bioinformatic analysis. SiHa cells were used for in-vitro and in-vivo analysis. Co-immunoprecipitation (Co-IP) assay was conducted to explore the proteins interacted with MAP7. Results showed that MAP7 mRNA expression might serve as an independent biomarker of shorter survival. MAP7 overexpression elevated cyclin D1/cyclin B1 expression, facilitated cell-cycle progression and promoted SiHa cell growth in a xenograft tumor model. Co-IP experiments confirmed a novel interaction between MAP7 and RC3H1. Knockdown of either RC3H1 or MAP7 significantly attenuated cyclin D1/cyclin B1 upregulation, and cell-cycle progression induced by the other partner. MAP7 overexpression led to increased expression of P-IKK (Ser176/177) and P-p65 (Ser536). RC3H1 inhibition abrogated MAP7 induced upregulation of P-IKK and P-p65. Data in TCGA-CESC showed that MAP7 expression was positively correlated with its copy number segments, but was negatively correlated with the methylation level of three CpG sites within the gene locus. Demethylation treatment by 5-Aza-dC elevated both MAP7 mRNA and protein expression in a dose-dependent manner. In conclusion, this study revealed a novel interaction between MAP7 and RC3H1 in cervical cancer cells, which cooperatively enhanced cyclin D1/cyclin B1 expression and facilitated cell-cycle progression. These effects were at least partly mediated by activated canonical IKK/NF-kB signaling.
Insights
Microtubule-associated protein MAP7 and RC3H1 interact to drive cervical cancer cell cycle progression. This interaction elevates cyclin D1/B1 and activates IKK/NF-kB signaling, impacting patient survival.
Area of Science:
- Molecular Biology
- Oncology
- Cell Biology
Background:
- Ensconsin, encoded by the MAP7 gene, is a microtubule-associated protein implicated in cellular functions.
- Cervical cancer progression involves dysregulation of cell-cycle control mechanisms.
- Understanding novel protein interactions is crucial for identifying therapeutic targets in cervical cancer.
Purpose of the Study:
- To investigate the functional roles and interaction partners of MAP7 in cervical cancer cell-cycle progression.
- To explore the potential of MAP7 as a biomarker for patient survival.
- To elucidate the molecular mechanisms underlying MAP7's function in cervical cancer.
Main Methods:
- Bioinformatic analysis of TCGA-CESC and GTEx datasets for MAP7 expression and correlation with survival.
- In vitro and in vivo studies using SiHa cervical cancer cells.
- Co-immunoprecipitation (Co-IP) assays to identify MAP7 interacting proteins.
- Gene knockdown experiments and Western blotting to assess protein expression and signaling pathway activation (IKK/NF-kB).
Main Results:
- MAP7 mRNA expression is an independent biomarker associated with shorter survival in cervical cancer patients.
- MAP7 overexpression enhances cyclin D1/B1 levels, promotes cell-cycle progression, and tumor growth in vivo.
- A novel interaction between MAP7 and RC3H1 was confirmed; their coordinated action is essential for cyclin D1/B1 upregulation and cell-cycle promotion.
- MAP7-induced cell-cycle progression is mediated by the activation of canonical IKK/NF-kB signaling, involving increased P-IKK and P-p65 expression.
- MAP7 expression is regulated by copy number variations and DNA methylation, with demethylation enhancing its expression.
Conclusions:
- MAP7 and RC3H1 form a novel functional complex in cervical cancer cells that cooperatively drives cell-cycle progression.
- This interaction promotes cyclin D1/B1 expression and activates the IKK/NF-kB pathway, contributing to tumor growth.
- MAP7 serves as a potential prognostic biomarker and therapeutic target in cervical cancer.
More Related Videos
Related Concept Videos
Inhibition of Cdk Activity
MAPK Signaling Cascades
Negative Regulator Molecules
Mitogens and the Cell Cycle
Molecular Factors Affecting Cell Division
Several proteins function as internal regulators to ensure each cell cycle stage is completed faithfully before proceeding to the next. Regulator molecules may act directly or influence the activity or production of other...
Positive Regulator Molecules

